2. Search Result
Search Result
Results for "

lipid-like compound

" in MedChemExpress (MCE) Product Catalog:

8

Inhibitors & Agonists

7

Biochemical Assay Reagents

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-156448
    80-O14B

    		Liposome Cancer
    80-O14B is an cationic lipid-like compound for CRISPR/Cas9 delivery .
    80-O14B
  • HY-145793
    FTT5

    		Others Others
    FTT5 is a lipid-like compound for efficient delivery of long mRNAs in vivo.
    FTT5
  • HY-145799
    5A2-SC8
    1 Publications Verification

    		 Liposome Others
    5A2-SC8 is a degradable lipid-like compound (ester-based dendrimer) for small RNAs delivery.
    5A2-SC8
  • HY-W440683
    C13-112-tetra-tail

    		Liposome Others
    C13-112-tetra-tail is a cationic lipid-like compound containing a polar amino alcohol head group, four hydrophobic carbon-13 tails, and a PEG2 linker. C13-112-tetra-tail can be formulated into a lipid nanoparticle (LNP).
    C13-112-tetra-tail
  • HY-W440681
    C13-112-tri-tail

    		Liposome Others
    C13-112-tri-tail is a cationic lipid-like compound containing a polar amino alcohol head group, three hydrophobic carbon-13 tails, and a PEG2 linker. C13-112-tri-tail can be formulated into a lipid nanoparticle (LNP).
    C13-112-tri-tail
  • HY-W440684
    C13-113-tetra-tail

    		Liposome Others
    C13-113-tetra tail is a cationic lipid-like compound containing a polar amino alcohol head group, four hydrophobic carbon-13 tails, and a tertiary amine linker. C13-113-tetra tail can be formulated into a lipid nanoparticle (LNP).
    C13-113-tetra-tail
  • HY-W440682
    C13-113-tri-tail

    		Liposome Others
    C13-113-tri tail is a cationic lipid-like compound containing a polar amino alcohol head group, three hydrophobic carbon-13 tails, and a tertiary amine linker. C13-113-tri tail can be formulated into a lipid nanoparticle (LNP).
    C13-113-tri-tail
  • HY-152229
    G0-C14

    		Liposome Cancer
    G0-C14 is a cationic lipid-like compound alkyl-modified polyamidoamine (PAMAM) dendrimer. G0-C14 involves in the preparation of a series of macrophage-targeted nanoparticles (NPs). NPs can be used for agent and vaccine delivery .
    G0-C14

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: